CLINICAL_TRIALS
trial_result
· 2025-01-27
Clinical Trial Update: Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies [Phase 2]
Summary
Phase 2 clinical trial update reporting results from a study in prostate cancer evaluating maximal androgen depletion followed by randomization to molecular tar…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-01-27